79 related articles for article (PubMed ID: 25823456)
1. Modulation of ConA-induced inflammatory ascites by histamine - short communication.
Baintner K
Acta Microbiol Immunol Hung; 2015 Mar; 62(1):87-91. PubMed ID: 25823456
[TBL] [Abstract][Full Text] [Related]
2. Inhibition of mast cell degranulation-induced drop of blood pressure with clemastine, cromolyn and compound 48/80 pretreatment.
Peternel L; Cerne M; Drevensek G; Stempelj M; Urleb U; Stanovnik L; Budihna MV
Inflamm Res; 2006 Apr; 55 Suppl 1():S07-8. PubMed ID: 16705372
[No Abstract] [Full Text] [Related]
3. [Pharmacological studies on oxatomide: (4) Effect on the histamine release from isolated rat peritoneal exudate cells (PEC) and lung slices].
Ohmori K; Ishii H; Shuto K; Nakamizo N
Nihon Yakurigaku Zasshi; 1982 Dec; 80(6):441-9. PubMed ID: 6186585
[TBL] [Abstract][Full Text] [Related]
4. Effect of cromolyn sodium and of daily exposure to compound 48/80 on experimental asthma.
Ambrus LC; Thurber L
Res Commun Chem Pathol Pharmacol; 1975 Jul; 11(3):491-4. PubMed ID: 239445
[TBL] [Abstract][Full Text] [Related]
5. Anti-anaphylactic activity of the novel selective histamine H1 receptor antagonist mizolastine in the rodent.
Levrier J; Duval D; Prouteau M; Voltz C; Berry CN; Lloyd KG; Scatton B
Arzneimittelforschung; 1995 May; 45(5):559-68. PubMed ID: 7541995
[TBL] [Abstract][Full Text] [Related]
6. Pycnogenol inhibits the release of histamine from mast cells.
Sharma SC; Sharma S; Gulati OP
Phytother Res; 2003 Jan; 17(1):66-9. PubMed ID: 12557250
[TBL] [Abstract][Full Text] [Related]
7. Contribution of the Kallikrein/Kinin System to the Mediation of ConA-Induced Inflammatory Ascites.
Baintner K
Acta Microbiol Immunol Hung; 2016 Mar; 63(1):131-7. PubMed ID: 27020875
[TBL] [Abstract][Full Text] [Related]
8. Suppression of ConA-induced inflammatory ascites by lipopolysaccharide (LPS) in mice.
Baintner K
Acta Microbiol Immunol Hung; 2012 Sep; 59(3):387-92. PubMed ID: 22982642
[TBL] [Abstract][Full Text] [Related]
9. Mucosal mast cells. II. Effects of anti-allergic compounds on histamine secretion by isolated intestinal mast cells.
Pearce FL; Befus AD; Gauldie J; Bienenstock J
J Immunol; 1982 Jun; 128(6):2481-6. PubMed ID: 6176639
[TBL] [Abstract][Full Text] [Related]
10. Influence of Ketotifen, Cromolyn Sodium, and Compound 48/80 on the survival rates after intestinal ischemia reperfusion injury in rats.
Hei ZQ; Gan XL; Huang PJ; Wei J; Shen N; Gao WL
BMC Gastroenterol; 2008 Sep; 8():42. PubMed ID: 18808687
[TBL] [Abstract][Full Text] [Related]
11. Tribenoside as an inhibitor of chemically induced histamine release.
Rüegg M; Jaques R
Experientia; 1974 Apr; 30(4):399-401. PubMed ID: 4135153
[No Abstract] [Full Text] [Related]
12. Degranulation of uterine mast cell modifies contractility of isolated myometrium from pregnant women.
Bytautiene E; Vedernikov YP; Saade GR; Romero R; Garfield RE
Am J Obstet Gynecol; 2004 Nov; 191(5):1705-10. PubMed ID: 15547545
[TBL] [Abstract][Full Text] [Related]
13. A method for determining whether hypotension caused by novel compounds in preclinical development results from histamine release.
Blom JD; Yang PC; Nicholson NS; Case BL; Parlow JJ; South MS; Wegner CD
J Pharmacol Toxicol Methods; 2004; 49(1):31-7. PubMed ID: 14670692
[TBL] [Abstract][Full Text] [Related]
14. Mast cell expression of the serotonin1A receptor in guinea pig and human intestine.
Wang GD; Wang XY; Zou F; Qu M; Liu S; Fei G; Xia Y; Needleman BJ; Mikami DJ; Wood JD
Am J Physiol Gastrointest Liver Physiol; 2013 May; 304(10):G855-63. PubMed ID: 23518679
[TBL] [Abstract][Full Text] [Related]
15. Combined Inhibition of Histamine H1 Receptors and Leukotrienes Reduces Compound 48/80-Induced Contraction of the Human Bronchus in vitro.
Benko R; Molnar TF; Szombati V; Benkö I; Bartho L
Pharmacology; 2015; 96(5-6):253-5. PubMed ID: 26394300
[TBL] [Abstract][Full Text] [Related]
16. Pentosanpolysulfate inhibits mast cell histamine secretion and intracellular calcium ion levels: an alternative explanation of its beneficial effect in interstitial cystitis.
Chiang G; Patra P; Letourneau R; Jeudy S; Boucher W; Green M; Sant GR; Theoharides TC
J Urol; 2000 Dec; 164(6):2119-25. PubMed ID: 11061939
[TBL] [Abstract][Full Text] [Related]
17. Interaction of toluidine blue and rat mast cells: histamine release and uptake and release of the dye.
Johnson AR; Moran NC
J Pharmacol Exp Ther; 1974 Apr; 189(1):221-34. PubMed ID: 4132668
[No Abstract] [Full Text] [Related]
18. Effect of dehydroleucodine on histamine and serotonin release from mast cells in the isolated mouse jejunum.
Penissi AB; Rudolph MI; Villar M; Coll RC; Fogal TH; Piezzi RS
Inflamm Res; 2003 May; 52(5):199-205. PubMed ID: 12813624
[TBL] [Abstract][Full Text] [Related]
19. Ketotifen: a histamine release inhibitor.
Martin U; Roemer D
Monogr Allergy; 1977; 12():145-9. PubMed ID: 72350
[No Abstract] [Full Text] [Related]
20. Compound 48/80, a histamine-depleting agent, blocks the protective effect of morphine against electroconvulsive shock in mice.
Karadag CH; Dokmeci D; Dost T; Ulugol A; Dokmeci I
Braz J Med Biol Res; 2000 Mar; 33(3):327-30. PubMed ID: 10719385
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
